Body Composition Analysis as An Indicator of Steatosis Severity in Metabolic Dysfunction-associated Steatotic Liver Disease (Formerly known as Non-Alcoholic Fatty Liver Disease): - Egyptian Knowledge Bank

418895

Body Composition Analysis as An Indicator of Steatosis Severity in Metabolic Dysfunction-associated Steatotic Liver Disease (Formerly known as Non-Alcoholic Fatty Liver Disease):

Article

Last updated: 09 Apr 2025

Overview Similar Items

Article

Metabolic Associated Fatty Liver Disease as the New Nomenclature for Nonalcoholic Fatty Liver Disease

Article

Cardiac Abnormalities in Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment

Article

Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Cross-Sectional Study

Article

New Screening non- invasive tool for Nonalcoholic Steatohepatitis in High-Risk Individuals

Article

Serum Adipsin as a Marker of MAFLD and its Relation with Metabolic Abnormalities

Article

Non-Alcoholic Fatty Liver Disease

Article

Diabetic and Non-Diabetic Non-Alcoholic Fatty Liver Disease Patients: Assessment Using Non-Invasive Diagnostic Tools

Article

Evaluation of Triglyceride-Glucose Index as a Marker of Hepatic Steatosis and Fibrosis in Egyptian Patients with NAFLD

Article

Severity of Coronary Artery Disease associated with Non-Alcoholic Fatty Liver

Article

Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods